致编辑的信：欧洲核医学与分子影像学会（EANM）甲状腺髓样癌PET/CT成像实践指南未引用F-NaF。 - Suppr

Suppr

超能文献

Letter to the Editor: F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.

作者信息

Duarte Paulo Schiavom

机构信息

Nuclear Medicine, Instituto do Câncer do Estado de São Paulo (ICESP), R Jupiter, Sao Paulo, SP, 01532-030, Brazil.

出版信息

Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):525-526. doi: 10.1007/s00259-019-04556-5. Epub 2019 Nov 18.

DOI:10.1007/s00259-019-04556-5

PMID:31741018

Abstract

摘要

相似文献

Letter to the Editor: F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.致编辑的信：欧洲核医学与分子影像学会（EANM）甲状腺髓样癌PET/CT成像实践指南未引用F-NaF。

Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):525-526. doi: 10.1007/s00259-019-04556-5. Epub 2019 Nov 18.

F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.F-18-多巴正电子发射断层扫描/计算机断层扫描比全身磁共振成像更敏感，可用于定位持续性/复发性甲状腺髓样癌患者的疾病。

Thyroid. 2019 Oct;29(10):1457-1464. doi: 10.1089/thy.2018.0351.

Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.转移性甲状腺髓样癌患者的（18）F-FDG-PET/CT和（111）In-奥曲肽SPECT多模态成像

Ann Nucl Med. 2016 Apr;30(3):234-41. doi: 10.1007/s12149-015-1056-5. Epub 2016 Jan 11.

18F-FDG PET Detection of a Medullary Thyroid Carcinoma in a Patient With SMZL.18F-FDG PET 检测到一名伴有 SMZL 的甲状腺髓样癌患者。

Clin Nucl Med. 2016 Oct;41(10):e447-8. doi: 10.1097/RLU.0000000000001290.

18F-Fluoride Uptake in Soft Tissue Metastases of Medullary Thyroid Carcinoma as a Marker of Progressive Calcification.18F-氟化物摄取在甲状腺髓样癌软组织转移作为进展性钙化的标志物。

Clin Nucl Med. 2018 Nov;43(11):848-849. doi: 10.1097/RLU.0000000000002259.

Diagnostic utility of PET/CT with F-DOPA and F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.F-DOPA 和 F-FDG PET/CT 对持续性或复发性甲状腺髓样癌的诊断价值：降钙素和癌胚抗原临界值的重要性。

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2004-2013. doi: 10.1007/s00259-017-3759-4. Epub 2017 Jun 23.

(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.（18）F-DOPA正电子发射断层扫描/计算机断层扫描在持续性甲状腺髓样癌诊断及定位中的应用

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1027-33. doi: 10.1007/s00259-015-3227-y. Epub 2015 Oct 24.

Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by F-FDOPA PET/CT in a MEN-2A asymptomatic patient.

Endocrine. 2019 Dec;66(3):691-692. doi: 10.1007/s12020-019-02074-w. Epub 2019 Sep 2.

Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases.68Ga-DOTATATE PET/CT 偶然发现神经内分泌肿瘤肝转移患者的甲状腺髓样癌。

Clin Nucl Med. 2018 Feb;43(2):136-138. doi: 10.1097/RLU.0000000000001950.

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma.钆塞酸增强 MRI 对 F-DOPA-PET/CT 用于甲状腺髓样癌肝脏分期的附加诊断价值。

Cancer Imaging. 2019 Nov 14;19(1):73. doi: 10.1186/s40644-019-0263-z.

引用本文的文献

Comparison of F-NaF PET/CT with Other Imaging Methods in the Detection of Bone Metastases in Patients with Medullary Thyroid Cancer: a Report of a Series of 31 Cases.F-NaF PET/CT与其他成像方法在检测甲状腺髓样癌患者骨转移中的比较：31例系列报告

Nucl Med Mol Imaging. 2020 Dec;54(6):281-291. doi: 10.1007/s13139-020-00666-3. Epub 2020 Sep 28.

F-Fluoride (F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!F-氟化物（F-氟化钠）PET/CT在甲状腺髓样癌中的应用：远离证据，远离指南！

Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):527-528. doi: 10.1007/s00259-019-04563-6.

本文引用的文献

EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.欧洲核医学与分子影像学会（EANM）甲状腺髓样癌PET/CT成像实践指南

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):61-77. doi: 10.1007/s00259-019-04458-6. Epub 2019 Sep 4.

Clin Nucl Med. 2018 Nov;43(11):848-849. doi: 10.1097/RLU.0000000000002259.

Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on F-Fluoride PET/CT than on Ga-Dotatate PET/CT.甲状腺髓样癌的骨和钙化软组织转移灶在F-氟化物PET/CT上比在镓-奥曲肽PET/CT上显示得更清晰。

Nucl Med Mol Imaging. 2018 Aug;52(4):318-323. doi: 10.1007/s13139-018-0527-8. Epub 2018 Jun 4.

177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT aid in personalized treatment decision making in selecting the best therapeutic option?177镥-奥曲肽与177镥-乙二胺四甲基膦酸对甲状腺髓样癌和神经内分泌肿瘤骨局限性疼痛性转移性疾病的疗效比较及联合/序贯治疗：68镥-奥曲肽和18F-氟化物PET-CT的半定量比较能否有助于在选择最佳治疗方案时做出个性化治疗决策？

Nucl Med Commun. 2016 Jan;37(1):100-2. doi: 10.1097/MNM.0000000000000397.

Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对甲状腺髓样癌淋巴结和肝转移的可视化。

Clin Nucl Med. 2015 Nov;40(11):895-6. doi: 10.1097/RLU.0000000000000939.

(18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.（18）F-NaF正电子发射断层显像/计算机断层扫描：欧洲核医学与分子影像学会骨显像程序指南

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1767-1777. doi: 10.1007/s00259-015-3138-y. Epub 2015 Jul 23.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。

Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.

¹⁸F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy.¹⁸F-氟化物 PET/CT 对于排除骨转移非常有效，即使在骨闪烁显像结果不明确的患者中也是如此。

Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1730-6. doi: 10.1007/s00259-012-2195-8. Epub 2012 Aug 4.

Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.肺癌患者骨转移的检测：99mTc-MDP 平面骨显像、18F-氟化物 PET 或 18F-FDG PET/CT。

Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1807-12. doi: 10.1007/s00259-009-1181-2. Epub 2009 Jun 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验